Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-1992 | 10-1991 | 07-1991 | 04-1991 | 01-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,514 | 2,510 | 2,563 | 2,529 | 2,053 |
| TOTAL | $2,514 | $2,510 | $2,563 | $2,529 | $2,053 |
| Non-Current Assets | |||||
| PPE Net | 7,939 | 7,804 | 7,632 | 7,773 | 8,099 |
| Other Non-Current Assets | 4,741 | 4,796 | 4,837 | 4,792 | 4,867 |
| TOTAL | $12,680 | $12,600 | $12,469 | $12,565 | $12,966 |
| Total Assets | $15,194 | $15,110 | $15,032 | $15,094 | $15,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,804 | 3,527 | 2,820 | 3,088 | 2,938 |
| Accrued Expenses | 2,454 | 2,653 | 3,210 | 2,471 | 2,098 |
| TOTAL | $7,452 | $7,398 | $6,619 | $6,785 | $6,942 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 767 | 751 | 736 | 721 | 706 |
| TOTAL | $2,530 | $2,562 | $2,434 | $2,395 | $2,354 |
| Total Liabilities | $9,982 | $9,960 | $9,053 | $9,180 | $9,296 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -254 | 447 | -298 | -403 | -281 |
| TOTAL | $19,424 | $20,125 | $21,380 | $22,275 | $22,397 |
| Total Liabilities And Equity | $29,406 | $30,085 | $30,433 | $31,455 | $31,693 |